妊娠期睡眠障碍与抗磷脂综合征的研究进展

覃 晓玲¹, 王 登兰²
1、新疆医科大学第二附属医院 新疆乌鲁木齐 830000
2、通讯作者新疆医科大学第二附属医院 新疆乌鲁木齐 830000

摘要

摘要：妊娠期睡眠障碍是引起不良妊娠结局的重要危险因素，良好的睡眠质量是健康妊娠的重要组成部分,大多数妊娠期妇女患有妊娠相关睡眠障碍,因此应当提高对孕期睡眠障碍的认知，及时进行干预，保障母婴健康,降低不良妊娠结局的发生。目前国内外研究表明成人自身免疫性疾病可通过多种生理途径对睡眠状况产生影响，但在妊娠期女性这个特殊群体中，鲜有关于妊娠期睡眠和抗磷脂综合症之间的相关性的研究。本研究将对妊娠期抗磷脂综合症，睡眠障碍，睡眠障碍和抗磷脂综合症的关系进行综述。

关键词

关键词:睡眠障碍;产科抗磷脂综合征;妊娠结局

参考

[1]ómez-Puerta A J ,Cervera R . Diagnosis and classification of the antiphospholipid syndrome[J]. Journal of Autoimmunity,2014,48-49.[2]Islam MA, Alam F, Gan SH,et al. A ,et al. 15-year single centre retrospective study of antiphospholipid syndrome patients from Northern Malaysia. Malays J Pathol. 2017;39(2):123-133.[3]Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296-1304.[4]Ruffatti A, Favaro M, Calligaro A,et al. Management of pregnant women with antiphospholipid antibodies. Expert Rev Clin Immunol. 2019;15(4):347-358.[5]Ruiz-Irastorza G, Crowther M, Branch W, et al. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498-1509.[6]赵久良,沈海丽,柴克霞等.抗磷脂综合征诊疗规范[J].中华内科杂志,2022,61(09):1000-1007[7]产科抗磷脂综合征诊断与处理专家共识[J].中华围产医学杂志,2020,23(08):517-522.[8]Chaturvedi S, Braunstein EM, Brodsky RA. Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications. J Thromb Haemost. 2021;19(3):607-616.[9]Gelaye B, Barrios YV, Zhong QY, et al. Association of poor subjective sleep quality with suicidal ideation among pregnant Peruvian women. Gen Hosp Psychiatry. 2015;37(5):441-447.[10]Mellor R, Chua SC, Boyce P. Antenatal depression: an artefact of sleep disturbance?. Arch Womens Ment Health. 2014;17(4):291-302.[11]Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2016;80(1):40-52.[12]Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019;19(11):702-715.[13]Beihl DA, Liese AD, Haffner SM. Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. Ann Epidemiol. 2009;19(5):351-357.[14]Nahum Sacks K, Friger M, Shoham-Vardi I, et al. Prenatal exposure to gestational diabetes mellitus as an independent risk factor for long-term neuropsychiatric morbidity of the offspring. Am J Obstet Gynecol. 2016;215(3):380.e1-380.e3807.[15]Svensson T, Saito E, Svensson AK, et al. Association of Sleep Duration With All- and Major-Cause Mortality Among Adults in Japan, China, Singapore, and Korea. JAMA Netw Open. 2021;4(9):e2122837. Published 2021 Sep 1.[16]Mindell JA, Cook RA, Nikolovski J. Sleep patterns and sleep disturbances across pregnancy. Sleep Med. 2015;16(4):483-488.[17]Kızılırmak A, Timur S, Kartal B. Insomnia in pregnancy and factors related to insomnia. ScientificWorldJournal. 2012;2012:197093.[18]Nodine PM, Matthews EE. Common sleep disorders: management strategies and pregnancy outcomes. J Midwifery Womens Health. 2013;58(4):368-377.[19]Clinton JM, Davis CJ, Zielinski MR, et al. Biochemical regulation of sleep and sleep biomarkers. J Clin Sleep Med. 2011;7(5 Suppl):S38-S42.[20]Chiu YL, Chuang YF, Fang KC, et al. Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. Nephrol Dial Transplant. 2009;24(1):247-251.[21]Weinberger JF, Raison CL, Rye DB, et al. Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation. Brain Behav Immun. 2015;47:193-200.[22]Ferrie JE, Kivimäki M, Akbaraly TN, et al. Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II Study. Am J Epidemiol. 2013;178(6):956-961.[23]Yin J, Gong R, Zhang M, et al. Associations between sleep disturbance, inflammatory markers and depressive symptoms: Mediation analyses in a large NHANES community sample. Prog Neuropsychopharmacol Biol Psychiatry. 2023;126:110786.[24]Davis CJ, Krueger JM. Sleep and Cytokines. Sleep Med Clin. 2012;7(3):517-527.[25]Lacourt TE, Vichaya EG, Chiu GS, et al . The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure. Front Behav Neurosci. 2018;12:78. Published 2018 Apr 26.[26]Atkins C, Wilson AM. Managing fatigue in sarcoidosis - A systematic review of the evidence. Chron Respir Dis. 2017;14(2):161-173.[27]Salvi V, Gianello V, Tiberio L, et al. Cytokine Targeting by miRNAs in Autoimmune Diseases. Front Immunol. 2019;10:15. Published 2019 Jan 29.[28]Kuwabara T, Ishikawa F, Kondo M, et al. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases. Mediators Inflamm. 2017;2017:3908061.[29]Zielinski MR, McKenna JT, McCarley RW. Functions and Mechanisms of Sleep. AIMS Neurosci. 2016;3(1):67-104.[30]Al-Diwani A, Handel A, Townsend L, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235-246.[31]Braley TJ, Segal BM, Chervin RD. Obstructive sleep apnea and fatigue in patients with multiple sclerosis. J Clin Sleep Med. 2014;10(2):155-162. Published 2014 Feb 15.[32]Ning P, Hu F, Yang B, et al. Systematic review and meta-analysis of observational studies to understand the prevalence of restless legs syndrome in multiple sclerosis: an update. Sleep Med. 2018;50:97-104.[33]Högl B, Heidbreder A, Santamaria J, et al. IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet. 2015;385(9977):1590.[34]Silber MH. Autoimmune sleep disorders. Handb Clin Neurol. 2016;133:317-326.[35]Katz Sand I. Neuromyelitis Optica Spectrum Disorders. Continuum (Minneap Minn). 2016;22(3):864-896.[36]Song Y, Pan L, Fu Y, et al. Sleep abnormality in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2015;2(3):e94. Published 2015 Apr 16.[37]Karkare K, Sinha S, Taly AB, Rao S. Prevalence and profile of sleep disturbances in Guillain-Barre Syndrome: a prospective questionnaire-based study during 10 days of hospitalization. Acta Neurol Scand. 2013;127(2):116-123.[38]Bahnasy WS, El-Heneedy YAE, El-Shamy AM, et al. Sleep and psychiatric abnormalities in Gullian Barré Syndrome. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):5.[39]Gao J, Li Y, Sun Y, et al. The study of sleep disorder factors in patients with Guillain-Barré syndrome. Int J Neurosci. 2016;126(10):893-898[40]Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2):241-255.[41]Abou-Zeid E, Boursoulian LJ, Metzer WS, Gundogdu B. Morvan syndrome: a case report and review of the literature. J Clin Neuromuscul Dis. 2012;13(4):214-227.[42]中华医学会神经病学分会睡眠障碍学组.中国发作性睡病诊断与治疗指南(2022 版)[J].中华神经科杂志,2022,55(05):406-420.[43]Gaig C, Graus F, Compta Y, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88(18):1736-1743.[44]Knaack L, Janicki J. Rheumatologische Erkrankungen und Schlaf –Schlafmedizinische Aspekte der Diagnostik und Therapie – Eine literaturbasierte Übersicht [Rheumatological Diseases and Sleep: Somnological Aspects of Diagnostics and Therapy]. Laryngorhinootologie. 2019;98(11):776-788.[45]Opp MR. Cytokines and sleep. Sleep Med Rev. 2005;9(5):355-364.[46]Chandrasekhara PK, Jayachandran NV, Rajasekhar L, et al. The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol. 2009;19(4):407-415.[47]Vina ER, Green SL, Trivedi T, et al. Correlates of sleep abnormalities in systemic lupus: a cross-sectional survey in an urban, academic center. J Clin Rheumatol. 2013;19(1):7-13.[48]Grabovac I, Haider S, Berner C, et al. Sleep Quality in Patients with Rheumatoid Arthritis and Associations with Pain, Disability, Disease Duration, and Activity. J Clin Med. 2018;7(10):336. Published 2018 Oct 9.[49]Chung WS, Lin CL. Sleep disorders associated with risk of rheumatoid arthritis. Sleep Breath. 2018;22(4):1083-1091.[50]Taylor-Gjevre RM, Gjevre JA, Skomro R, et al. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol. 2009;15(1):12-15.[51]Chung SW, Hur J, Ha YJ, et al. Impact of sleep quality on clinical features of primary Sjögren's syndrome. Korean J Intern Med. 2019;34(5):1154-1164.[52]Priori R, Minniti A, Antonazzo B, et al. Sleep quality in patients with primary Sjögren's syndrome. Clin Exp Rheumatol. 2016;34(3):373-379.[53]Segal BM, Pogatchnik B, Henn L, et al. Pain severity and neuropathic pain symptoms in primary Sjögren's syndrome: a comparison study of seropositive and seronegative Sjögren's syndrome patients. Arthritis Care Res (Hoboken). 2013;65(8):1291-1298.[54]de Oliveira LV, Sinicato NA, Appenzeller S, et al. Sleep disorders in primary antiphospholipid syndrome. Clin Rheumatol. 2018;37(12):3345-3349